C
5.69
-0.08 (-1.39%)
| Previous Close | 5.77 |
| Open | 5.67 |
| Volume | 354,243 |
| Avg. Volume (3M) | 366,086 |
| Market Cap | 283,990,176 |
| Price / Sales | 1.32 |
| Price / Book | 0.830 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2025 - 9 May 2025 |
| Profit Margin | -50.25% |
| Operating Margin (TTM) | -27.44% |
| Diluted EPS (TTM) | -2.49 |
| Quarterly Revenue Growth (YOY) | 4.00% |
| Total Debt/Equity (MRQ) | 62.38% |
| Current Ratio (MRQ) | 5.29 |
| Operating Cash Flow (TTM) | -16.32 M |
| Levered Free Cash Flow (TTM) | -9.81 M |
| Return on Assets (TTM) | -4.98% |
| Return on Equity (TTM) | -25.76% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Integrated Freight & Logistics (US) | Bearish | Bearish |
| Integrated Freight & Logistics (Global) | Bearish | Bearish | |
| Stock | CryoPort, Inc. | Bullish | Bearish |
AIStockmoo Score
0.2
| Analyst Consensus | 4.0 |
| Insider Activity | -1.5 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | 0.20 |
|
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas. |
|
| Sector | Industrials |
| Industry | Integrated Freight & Logistics |
| Investment Style | Small Value |
| % Held by Insiders | 2.67% |
| % Held by Institutions | 101.04% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Thematics Asset Management | 31 Dec 2024 | 1,705,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 15.00 (Roth MKM, 163.62%) | Buy |
| Median | 11.00 (93.32%) | |
| Low | 11.00 (UBS, 93.32%) | Buy |
| 11.00 (Needham, 93.32%) | Buy | |
| Average | 12.33 (116.70%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 6.09 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Needham | 01 Apr 2025 | 11.00 (93.32%) | Buy | 6.09 |
| 31 Mar 2025 | 11.00 (93.32%) | Buy | 6.08 | |
| Roth MKM | 01 Apr 2025 | 15.00 (163.62%) | Buy | 6.09 |
| UBS | 01 Apr 2025 | 11.00 (93.32%) | Buy | 6.09 |
| 24 Mar 2025 | 10.00 (75.75%) | Buy | 7.10 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| SAWICKI MARK W | - | 7.10 | -1,349 | -9,578 |
| SHELTON JERRELL | - | 7.10 | -2,980 | -21,158 |
| STEFANOVICH ROBERT | - | 7.10 | -1,070 | -7,597 |
| Aggregate Net Quantity | -5,399 | |||
| Aggregate Net Value ($) | -38,333 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 7.10 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SHELTON JERRELL | Officer | 24 Mar 2025 | Sell (-) | 2,980 | 7.10 | 21,158 |
| STEFANOVICH ROBERT | Officer | 24 Mar 2025 | Sell (-) | 1,070 | 7.10 | 7,597 |
| SAWICKI MARK W | Officer | 24 Mar 2025 | Sell (-) | 1,349 | 7.10 | 9,578 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |